Tech Company Financing Transactions
Drais Pharmaceuticals Funding Round
Drais Pharmaceuticals, operating out of Bridgewater, secured $20 million from InterWest Partners.
Transaction Overview
Company Name
Announced On
3/31/2010
Transaction Type
Venture Equity
Amount
$20,000,000
Round
Undisclosed
Investors
InterWest Partners (Arnold Oronsky)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
520 US Hwy. 22 201
Bridgewater, NJ 08807
USA
Bridgewater, NJ 08807
USA
Phone
Website
Email Address
Overview
Drais Pharmaceuticals, Inc. is a privately held drug development company based in Bridgewater, New Jersey. We are focused on early and mid-stage clinical development, through proof of concept, with a current pipeline of three compounds.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Donna Tempel
Co-Founder
Robert Desjardins
VP - Finance
Christopher Mastro
VP - Product Management
Robert Schinagl
Browse more venture capital transactions:
Prev: 3/31/2010: Oasys Water venture capital transaction
Next: 3/31/2010: GroundedPower venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs